Literature DB >> 18787909

Preoperative liver function tests and hemoglobin will predict complications following pancreaticoduodenectomy.

Christopher Hughes1, Michael G Hurtuk, Karen Rychlik, Margo Shoup, Gerard V Aranha.   

Abstract

INTRODUCTION: Previous studies identified an association between dilated pancreatic and biliary ducts and lower rates of pancreatic leak after pancreaticoduodenectomy, but it remains unclear whether elevated liver function tests are also associated with lower rates of complications. The purpose of this study was to determine if preoperative liver function tests are associated with postoperative complications.
MATERIALS AND METHODS: We identified 452 patients who received a pancreaticoduodenectomy from 1990-2007. Clinicopathological data was collected for each patient, and regression analyses were performed to identify predictors of postoperative complications.
RESULTS: Of the patients studied, 289 (64%) experienced no postoperative complications. In univariate analysis, patients with a low or normal preoperative aspartate aminotransferase (p = 0.03) or alkaline phosphatase (p = 0.03), had higher rates of complications. Multivariate analysis confirmed an elevated alkaline phosphatase was associated with a lower incidence of complications (OR = 0.56, p = 0.02), while preoperative anemia was found to be a predictor of complications following pancreaticoduodenectomy (OR = 2.01, p = 0.02).
CONCLUSION: Anemic patients and those with normal liver function tests were more likely to experience complications after pancreaticoduodenectomy. This may represent extent of disease and tumors not causing biliary or pancreatic dilatation, respectively. Precautions, such as intraoperative ductal stents, should be considered when operating on this group of patients to minimize complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787909     DOI: 10.1007/s11605-008-0680-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant.

Authors:  M I van Berge Henegouwen; L T De Wit; T M Van Gulik; H Obertop; D J Gouma
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

2.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

3.  Risk factors of pancreatic leakage after pancreaticoduodenectomy.

Authors:  Yin-Mo Yang; Xiao-Dong Tian; Yan Zhuang; Wei-Min Wang; Yuan-Lian Wan; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial.

Authors:  Keith D Lillemoe; John L Cameron; Min P Kim; Kurtis A Campbell; Patricia K Sauter; Joann A Coleman; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

5.  Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program.

Authors:  Kevin G Billingsley; Kwan Hur; William G Henderson; Jennifer Daley; Shukri F Khuri; Richard H Bell
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

6.  Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery.

Authors:  Wen-Chih Wu; Tracy L Schifftner; William G Henderson; Charles B Eaton; Roy M Poses; Georgette Uttley; Satish C Sharma; Michael Vezeridis; Shukri F Khuri; Peter D Friedmann
Journal:  JAMA       Date:  2007-06-13       Impact factor: 56.272

7.  Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study.

Authors:  J Gibbs; W Cull; W Henderson; J Daley; K Hur; S F Khuri
Journal:  Arch Surg       Date:  1999-01

8.  An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy.

Authors:  C A Pellegrini; C F Heck; S Raper; L W Way
Journal:  Arch Surg       Date:  1989-07

9.  Optimal management of the pancreatic remnant after pancreaticoduodenectomy.

Authors:  S G Marcus; H Cohen; J H Ranson
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  3 in total

1.  Improving the treatment of pre-operative anemia in hepato-pancreato-biliary patients: a quality improvement initiative.

Authors:  Terry M Zwiep; Richard W D Gilbert; Husein Moloo; Donna Touchie; Guillaume Martel; Tom Wallace; Kimberly A Bertens
Journal:  Patient Saf Surg       Date:  2020-04-24

2.  Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique.

Authors:  Sidney Olefson; Melissa Jackson; David J Grand; Kevin P Charpentier; Nirav Makwana; Kittichai Promrat
Journal:  J Clin Transl Hepatol       Date:  2015-12-15

3.  Age-dependent relationship between preoperative serum aminotransferase and mortality after cardiovascular surgery.

Authors:  Jae-Sik Nam; Wook-Jong Kim; Sang-Mee An; Dae-Kee Choi; Ji-Hyun Chin; Eun-Ho Lee; In-Cheol Choi
Journal:  Aging (Albany NY)       Date:  2019-10-18       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.